Our AbTheneum single B cell antibody discovery platform lets you capture the future – by overcoming the limitations of the past.
Single Cell’s pioneering AbTheneum platform was specifically developed to tackle the well-known challenges that typically come with antibody discovery.
Instead of having to literally pick just a handful of cells to work with early in the process – and leave huge amounts of data and possible pathways unexplored – it’s now possible to collect quality data from every single cell on our 90,000-well devices. And that data is yours to mine as often and for as long as you like.
